Ascendis Pharma A (ASND) Change in Cash (2014 - 2026)

Ascendis Pharma A has reported Change in Cash for 13 years, with the latest figure at -$60.1 million in Q1 2026.

• Quarterly Change in Cash fell 72.83% year-over-year to -$60.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.9 million (down 66.77% YoY) and the FY2025 annual result came in at $95.1 million, down 57.98% from the prior year.
• Change in Cash eased to -$60.1 million in Q1 2026 per ASND's latest filing, from $91.4 million in the prior quarter.
• Over five years, Change in Cash peaked at $848.1 million in Q1 2022 and troughed at -$118.1 million in Q2 2023.
• A 5-year average of $70.3 million and a median of -$20.0 million in 2025 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 816.62% in 2024, down 222.3% in 2024.
• Over 5 years, Change in Cash stood at -$64.6 million in 2022, then surged by 168.87% to $44.5 million in 2023, then surged by 816.62% to $407.7 million in 2024, then sank by 77.58% to $91.4 million in 2025, then slumped by 165.72% to -$60.1 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$60.1 million, $91.4 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.